Defense Biotechnology Strategy Act

# Defense Biotechnology Strategy Act (HR 6009) – Summary **What the Bill Would Do** This bill would require the Department of Defense (DoD) to develop and implement a comprehensive strategy for biotechnology research and development. The strategy would guide how the military uses biotechnology—which includes genetic engineering, synthetic biology, and related biological innovations—for defense purposes. By establishing a coordinated national approach, the bill aims to ensure the U.S. military can effectively leverage advances in biotechnology while maintaining ethical standards and security safeguards. **Who It Affects and Key Provisions** The bill primarily affects the Department of Defense, military research institutions, and potentially private biotechnology companies that work with the military.

It would likely require the DoD to set goals, allocate resources, coordinate between different military branches and agencies, and establish oversight mechanisms. The bill may also address workforce development, research partnerships with universities and private sector, and security measures to protect sensitive biotechnology research from foreign adversaries. **Current Status** As of now, HR 6009 remains in committee, meaning it has not yet been voted on by the full House. The bill was introduced by Representative Chrissy Houlahan (D-PA) and is still in the early stages of the legislative process.